BackTable / VI / Podcast / Episode #64

Bridging to Transplant for HCC

with Dr. Jennifer Berumen and Dr. Isabel Newton

Transplant Surgeon Dr. Jennifer Berumen and Interventional Radiologist Dr. Isabel Newton discuss the treatment of HCC and the importance of multi-specialty collaboration in bridging these patients to successful liver transplantation. Special discussion was given around this HCC consortium article in Annals of Surgery: https://pubmed.ncbi.nlm.nih.gov/30870180/

Sponsored by:

TriSalus Life Sciences
Bridging to Transplant for HCC with Dr. Jennifer Berumen and Dr. Isabel Newton on the BackTable VI Podcast)
Ep 64 Bridging to Transplant for HCC with Dr. Jennifer Berumen and Dr. Isabel Newton
00:00 / 01:04

BackTable, LLC (Producer). (2020, May 21). Ep. 64 – Bridging to Transplant for HCC [Audio podcast]. Retrieved from https://www.backtable.com

BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Jennifer Berumen discusses Bridging to Transplant for HCC on the BackTable 64 Podcast

Dr. Jennifer Berumen

Dr. Jennifer Berumen is a transplant surgeon and assistant professor with the UCSD Department of Surgery in San Diego.

Dr. Isabel Newton discusses Bridging to Transplant for HCC on the BackTable 64 Podcast

Dr. Isabel Newton

Dr. Isabel Newton is a practicing interventional radiologist at UC San Diego Health in San Diego, CA.

Dr. Christopher Beck discusses Bridging to Transplant for HCC on the BackTable 64 Podcast

Dr. Christopher Beck

Dr. Chris Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.

Show Notes

• Milan Criteria:
https://www.mdcalc.com/milan-criteria-liver-transplantation

• Criteria for Liver Transplantation in Hepatocellular Carcinoma:
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/cld.499

• The Interventional Initiative:
http://www.theii.org/

• Paper discussed:
DiNorcia J, Florman SS, Haydel B, et al. Pathologic Response to Pretransplant Locoregional
Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular
Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg.
2020;271(4):616‐624. doi:10.1097/SLA.0000000000003253

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Earn CME When You Listen to BackTable CMEfy

Up Next

Making Informed Consent an Informed Choice with the Interventional Initiative with Dr. Isabel Newton, Margaret Simor, MSN, and Susan Jackson MBA on the BackTable VI Podcast)
Cholecystostomy Tubes with Dr. Christopher Beck on the BackTable VI Podcast)
Discussing the Complications Survey Results with the BackTable Team on the BackTable VI Podcast)
Mediport Placement with Dr. Christopher Beck and Dr. Aaron Fritts on the BackTable VI Podcast)
Road to Becoming a Y90 Authorized User (While in Training!) with Dr. Rakesh Ahuja on the BackTable VI Podcast)
New Tools to Treat Severe Distal Femoropopliteal Disease with Dr. John Rundback on the BackTable VI Podcast)

Articles

Hepatocellular carcinoma on CT

HCC Locoregional Therapies for Bridging to Transplant

Hepatocellular carcinoma on angiography

Patient Selection and Treatment of Hepatocellular Carcinoma

Topics

Hepatocellular Carcinoma Condition Overview
TACE Procedure Steps & Treatment
Y90 Radioembolization Procedure Prep

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.